Organisation for Anti-Convulsant Syndrome
Registered Charity No. 1116497
UK Helpline: 07904 200364
The Valproate Toolkit - Ireland
The HSE has published a new toolkit on the drug sodium valproate (Epilim) for patients and prescribers.
The Valproate toolkit was produced by the National Clinical Programmes For Epilepsy, Mental Health and Medicines Management in consultation with the HPRA and patient groups.
It aims to reinforce the safety message for healthcare professionals and patients that Sodium valproate (Epilim) is not prescribed for girls or women of child-bearing age unless other treatments are not effective or are not tolerated.
Do not stop your medication unless you get advice from your Health Care Provider.
In 2014, the European Medicines Agency strengthened its warnings on the use of valproate in women and girls due to the increased risk of developmental problems, autism and malformations in children exposed to valproate in the womb
The online toolkit consists of:
Patient information booklet
Guidelines for prescribers
Patient/ Prescriber Checklist
Download the Patient Information booklet